These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 27600665)

  • 1. A critical review of recent developments in radiotherapy for non-small cell lung cancer.
    Baker S; Dahele M; Lagerwaard FJ; Senan S
    Radiat Oncol; 2016 Sep; 11(1):115. PubMed ID: 27600665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.
    Loganadane G; Martinetti F; Mercier O; Krhili S; Riet FG; Mbagui R; To H; Le Péchoux C; Levy A
    Cancer Treat Rev; 2016 Nov; 50():240-246. PubMed ID: 27768919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea.
    Song S; Chang JH; Kim HJ; Kim YS; Kim JH; Ahn YC; Kim JS; Song SY; Moon SH; Cho MJ; Youn SM
    Cancer Res Treat; 2017 Jul; 49(3):688-694. PubMed ID: 27809459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.
    Edwards JP; Datta I; Hunt JD; Stefan K; Ball CG; Dixon E; Grondin SC
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1599-606. PubMed ID: 26796110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
    Iyengar P; Westover K; Timmerman RD
    Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.
    Chang JY; Bezjak A; Mornex F;
    J Thorac Oncol; 2015 Apr; 10(4):577-85. PubMed ID: 25514807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy patterns of care for stage I and II non-small cell lung cancer in Sydney, Australia.
    Nguyen AD; Wong W; Beydoun N; Mohan S; Shafiq J; Vinod SK
    J Med Imaging Radiat Oncol; 2019 Feb; 63(1):131-141. PubMed ID: 30281917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiotherapy in oligometastatic cancer.
    Kennedy TAC; Corkum MT; Louie AV
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S16. PubMed ID: 28917254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic ablative radiotherapy for non-small cell lung cancer: rationale and outcomes.
    Iyengar P; Timmerman RD
    J Natl Compr Canc Netw; 2012 Dec; 10(12):1514-20. PubMed ID: 23221789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current Status of Stereotactic Ablative Radiotherapy (SABR) for Early-stage 
Non-small Cell Lung Cancer].
    Shi A; Zhu G
    Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):389-93. PubMed ID: 27335303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC).
    Navarria P; Ascolese AM; Mancosu P; Alongi F; Clerici E; Tozzi A; Iftode C; Reggiori G; Tomatis S; Infante M; Alloisio M; Testori A; Fogliata A; Cozzi L; Morenghi E; Scorsetti M
    Radiother Oncol; 2013 Jun; 107(3):414-8. PubMed ID: 23725859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do radiation oncologists require for future advancements in lung SBRT?
    Ricardi U; Badellino S; Filippi AR
    Phys Med; 2017 Dec; 44():150-156. PubMed ID: 27914779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges.
    Ishikura S
    Gen Thorac Cardiovasc Surg; 2012 Mar; 60(3):127-31. PubMed ID: 22419179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New radiotherapy approaches in locally advanced non-small cell lung cancer.
    Christodoulou M; Bayman N; McCloskey P; Rowbottom C; Faivre-Finn C
    Eur J Cancer; 2014 Feb; 50(3):525-34. PubMed ID: 24333095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Salvage surgery for locally recurrent lung cancer: options for patients who have been treated with high dose radiotherapy].
    Dickhoff C; Hashemi SMS; Symersky P; Paul MA; Dahele M
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer: Theory and Practice.
    Rusthoven CG; Yeh N; Gaspar LE
    Cancer J; 2015; 21(5):404-12. PubMed ID: 26389766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy for early stage lung cancer-historical developments and future strategies.
    Chua KLM; Sin I; Fong KW; Chua MLK; Onishi H
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S20. PubMed ID: 28917258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non-Small-Cell Lung Cancer: CEPO Review and Recommendations.
    Boily G; Filion É; Rakovich G; Kopek N; Tremblay L; Samson B; Goulet S; Roy I;
    J Thorac Oncol; 2015 Jun; 10(6):872-82. PubMed ID: 26001140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer - A Done Deal?
    Gulstene S; Ruwanpura T; Palma D; Joseph N
    Clin Oncol (R Coll Radiol); 2022 Nov; 34(11):733-740. PubMed ID: 36050221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.